Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cervomed Inc (CRVO)

Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cervomed Inc 20 Park Plaza Suite 424 Boston Boston MA 02216 USA

www.cervomed.com Employees: 15 P: 617-744-4400

Sector:

Medical

Description:

CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics for patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant which inhibits p38MAP kinase alpha. CervoMed Inc., formerly known as Diffusion Pharmaceuticals Inc., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 42,840
Enterprise Value, $K 33,840
Shares Outstanding, K 9,253
Float, K 5,977
% Float 64.60%
Short Interest, K 235
Short Float 2.54%
Days to Cover 2.25
Short Volume Ratio 0.52
% of Insider Shareholders 35.40%
% of Institutional Shareholders 25.15%

Financials:

Annual Sales, $ 9,740 K
Annual Net Income, $ -16,290 K
Last Quarter Sales, $ 320 K
Last Quarter Net Income, $ -7,730 K
EBIT, $ -27,200 K
EBITDA, $ -27,200 K

Growth:

1-Year Return 99.14%
3-Year Return -46.87%
5-Year Return -94.63%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.84 on 11/07/25
Next Earnings Date 03/16/26 [--]
Earnings Per Share ttm -2.90
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year -52.73%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 2-3 on 08/17/23

CRVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.78%
Return-on-Assets % -68.07%
Profit Margin % -167.25%
Debt/Equity 0.00
Price/Sales 6.95
Price/Cash Flow N/A
Price/Book 1.86
Book Value/Share 2.81
Interest Coverage -0.78
60-Month Beta -0.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar